We are live on ! Find out more
Ruffer

Ruffer Portfolio holdings

AUM $1.98B Turnover 35.71%
1-Year Est. Return 11.67%
 

Ruffer is an independent investment manager owned and run by its partners, with a single global strategy aimed at not losing money over any rolling 12-month period. Jonathan Ruffer, who began as a stockbroker and then became a barrister, started it in 1994 with Robert Shirley, 14th Earl Ferrers, and Jane Tufnell, and it became Ruffer LLP in 2004. The firm starts by weighing the risks it sees in markets and picking assets that should protect the portfolio if they come true, then takes on growth mainly through global stocks. It runs a stock-market-listed investment company, and its clients include pension plans, charities and family offices.

This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+11.67%
3 Year Est. Return
+123.28%
5 Year Est. Return
+179.62%
10 Year Est. Return
+587.82%
AUM
$3.27B
AUM Growth
+$320M
Cap. Flow
+$146M
Cap. Flow %
4.48%
Top 10 Hldgs %
67.68%
Holding
89
New
8
Increased
19
Reduced
31
Closed
13
Avg Time Held
2.3 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.9 years

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$147M
2
BMY icon
Bristol-Myers Squibb
BMY
+$145M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$102M
4
CI icon
Cigna
CI
+$82.3M
5
ABEV icon
Ambev
ABEV
+$79.6M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$191M
2
GM icon
General Motors
GM
+$59.5M
3
CX icon
Cemex
CX
+$54.3M
4
MSTR icon
Strategy Inc
MSTR
+$53.6M
5
SCHW icon
Charles Schwab
SCHW
+$50.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.75%
2 Financials 22.96%
3 Materials 22.22%
4 Consumer Staples 9.31%
5 Energy 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CNC icon
1
Centene
CNC
$35.3B
$354M 10.83%
5,536,706
+2,373,204
+75% +$147M
2019 Q3
6 quarters
CI icon
2
Cigna
CI
$78.3B
$326M 9.98%
1,348,700
+369,217
+38% +$82.3M
2018 Q3
10 quarters
ABEV icon
3
Ambev
ABEV
$42.5B
$269M 8.22%
97,480,397
+28,205,861
+41% +$79.6M
2020 Q4
1 quarter
BMY icon
4
Bristol-Myers Squibb
BMY
$130B
$265M 8.11%
4,196,856
+2,327,044
+124% +$145M
2019 Q2
7 quarters
KGC icon
5
Kinross Gold
KGC
$24.5B
$224M 6.85%
33,532,930
+6,942,948
+26% +$48.3M
2013 Q2
31 quarters
AXP icon
6
American Express
AXP
$215B
$220M 6.72%
1,551,574
-285,655
-16% -$37.7M
2020 Q2
3 quarters
SCHW icon
7
Charles Schwab
SCHW
$160B
$182M 5.56%
2,786,032
-830,070
-23% -$50.3M
2020 Q2
3 quarters
WPM icon
8
Wheaton Precious Metals
WPM
$59.7B
$137M 4.2%
3,590,891
+816,986
+29% +$32.4M
2015 Q3
22 quarters
EHTH icon
9
eHealth
EHTH
$13.4M
$133M 4.07%
1,830,110
+382,381
+26% +$24.4M
2019 Q4
5 quarters
GM icon
10
General Motors
GM
$72.5B
$103M 3.16%
1,799,132
-1,120,742
-38% -$59.5M
2018 Q2
11 quarters
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$100M 3.07%
+656,688
New +$102M
2021 Q1
0 quarters
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.26T
$99.5M 3.04%
389,041
-138,784
-26% -$33.7M
2020 Q2
3 quarters
CTRA icon
13
DELISTED
Coterra Energy
CTRA
$76.3M 2.33%
4,062,794
+1,289,128
+46% +$23.7M
2020 Q3
2 quarters
AU icon
14
AngloGold Ashanti
AU
$43.7B
$67.1M 2.05%
3,052,826
-565,697
-16% -$12.7M
2015 Q2
23 quarters
DIS icon
15
Walt Disney
DIS
$205B
$61.4M 1.88%
332,681
-1,037,565
-76% -$191M
2016 Q4
17 quarters
NTR icon
16
Nutrien
NTR
$33.8B
$57.3M 1.75%
1,063,520
+7,820
+0.7% +$425K
2020 Q3
2 quarters
AFL icon
17
Aflac
AFL
$63.1B
$52.4M 1.6%
1,022,473
-221,879
-18% -$10.6M
2020 Q3
2 quarters
NEM icon
18
Newmont
NEM
$118B
$52.2M 1.6%
865,474
+742,986
+607% +$44.5M
2015 Q4
21 quarters
JPM icon
19
JPMorgan Chase
JPM
$919B
$47.9M 1.47%
314,664
-55,956
-15% -$8.05M
2013 Q2
31 quarters
GFI icon
20
Gold Fields
GFI
$31.6B
$45.9M 1.4%
4,833,096
-2,596,764
-35% -$24.2M
2013 Q2
31 quarters
XOM icon
21
ExxonMobil
XOM
$696B
$38.1M 1.17%
682,944
+515,755
+308% +$27M
2013 Q2
31 quarters
EXE icon
22
Expand Energy Corp
EXE
$20.4B
$37.8M 1.16%
+870,000
New +$38.3M
2021 Q1
0 quarters
IAG icon
23
IAMGOLD
IAG
$9.8B
$33.4M 1.02%
11,225,371
-7,978,529
-42% -$26.4M
2018 Q4
9 quarters
CHKP icon
24
Check Point Software Technologies
CHKP
$15B
$29.8M 0.91%
266,512
-162,569
-38% -$19.6M
2018 Q4
9 quarters
GAU icon
25
Galiano Gold
GAU
$597M
$29.7M 0.91%
26,822,077
-192,339
-0.7% -$229K
2018 Q4
9 quarters

Similar funds

Ruffer's Q1 2021 Portfolio in Review

As of Q1 2021, Ruffer held 89 positions worth $3.27B, up 11% from $2.95B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Ruffer deployed $146M of net new capital in Q1 2021, opening 8 new positions and adding to 19 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 656,688 shares worth $100M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 18% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Walt Disney, an estimated $191M trimmed.

  • Ruffer's largest Q1 2021 buy was Alexion Pharmaceuticals: 656,688 shares worth $100M.
  • Ruffer added most to Centene in Q1 2021, an estimated $147M increase.
  • Ruffer's biggest Q1 2021 reduction was Walt Disney, cutting an estimated $191M.
  • Ruffer fully exited Strategy Inc in Q1 2021, selling an estimated $53.6M.
  • Ruffer's ten largest holdings make up 68% of its $3.27B portfolio in Q1 2021.
  • Ruffer opened 8 new positions and closed 13 in Q1 2021.
  • Ruffer's portfolio value rose 11% quarter-over-quarter to $3.27B.

Based on Ruffer's 13F filing for Q1 2021, filed 11 May 2021.